APA (7th ed.) Citation

IB, W., J, H., J, L., S, S., Y, C., H, Z., . . . PM, V. (2026). GFAP degradation in TBI: Linking novel modified products to astrocyte pathology and patient outcome. Acta neuropathologica communications, 14(1), . https://doi.org/10.1186/s40478-026-02240-y

Chicago Style (17th ed.) Citation

IB, Wanner, et al. "GFAP Degradation in TBI: Linking Novel Modified Products to Astrocyte Pathology and Patient Outcome." Acta Neuropathologica Communications 14, no. 1 (2026). https://doi.org/10.1186/s40478-026-02240-y.

MLA (9th ed.) Citation

IB, Wanner, et al. "GFAP Degradation in TBI: Linking Novel Modified Products to Astrocyte Pathology and Patient Outcome." Acta Neuropathologica Communications, vol. 14, no. 1, 2026, https://doi.org/10.1186/s40478-026-02240-y.